Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Mamede

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell and Tissue Research|May 18, 2012
Amniotic membrane: from structure and functions to clinical applicationsA C Mamede, M J Carvalho, A M Abrantes, et al.
Current Radiopharmaceuticals|January 28, 2012
Radiolabelling of ascorbic acid: a new clue to clarify its action as an anticancer agent?A C Mamede, A M Abrantes, A S Pires, et al.
Current Cancer Drug Targets|May 12, 2018
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?A P Alves, A C Mamede, M G Alves, et al.
Pathology Oncology Research : POR|March 12, 2016
Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular CarcinomaA C Mamede, S Guerra, M Laranjo, et al.
Chemotherapy|December 22, 2012
Hepatocellular carcinoma and chemotherapy: the role of p53A F Brito, A M Abrantes, C Pinto-Costa, et al.
ISRN Oncology|October 30, 2013
Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell lineA C Mamede, A M Abrantes, L Pedrosa, et al.
Medical Oncology (Northwood, London, England)|October 29, 2015
Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinomaA C Mamede, S Guerra, M Laranjo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell and Tissue Research|May 18, 2012
Amniotic membrane: from structure and functions to clinical applicationsA C Mamede, M J Carvalho, A M Abrantes, et al.
Current Radiopharmaceuticals|January 28, 2012
Radiolabelling of ascorbic acid: a new clue to clarify its action as an anticancer agent?A C Mamede, A M Abrantes, A S Pires, et al.
Current Cancer Drug Targets|May 12, 2018
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?A P Alves, A C Mamede, M G Alves, et al.
Pathology Oncology Research : POR|March 12, 2016
Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular CarcinomaA C Mamede, S Guerra, M Laranjo, et al.
Chemotherapy|December 22, 2012
Hepatocellular carcinoma and chemotherapy: the role of p53A F Brito, A M Abrantes, C Pinto-Costa, et al.
ISRN Oncology|October 30, 2013
Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell lineA C Mamede, A M Abrantes, L Pedrosa, et al.
Medical Oncology (Northwood, London, England)|October 29, 2015
Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinomaA C Mamede, S Guerra, M Laranjo, et al.
Pageof 1